<DOC>
	<DOCNO>NCT02587442</DOCNO>
	<brief_summary>This Phase 1 , non-randomized , sequential-cohort , dose escalation , open-label study design evaluate safety tolerability RadProtect® healthy volunteer . This study conduct two clinical center conformity Good Clinical Practice ( GCP ) .</brief_summary>
	<brief_title>A Study Evaluate Safety Pharmacokinetics RadProtect® Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Acute Radiation Syndrome</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>Each subject must willing able provide write informed consent study Healthy volunteer subject gender , age 1864 year old , race/ethnicity Subjects normal blood pressure ( range 120140/6080 mmHg ) screen baseline Subjects body mass index ( BMI ) 1830 kg/m2 Men woman childbearing potential use adequate contraception ( oral contraceptive , intrauterine device barrier method contraception conjunction spermicidal jelly , surgically sterile ) screening , receive investigational drug , 60 day stop investigational drug Female subject childbearing potential must negative urine pregnancy test screen Subjects physiological examination laboratory value within normal limit ( CBC/differential , blood chemistry , iron , Total Iron Binding Capacity ( TIBC ) , urinalysis , ECG vital sign ) Subjects ability comprehend complete telephone visit , screen , site visit Subjects must able adhere dose visit schedule Subjects agree abstain take unauthorized medication supplement participate clinical trial experimental treatment trial . Subjects allergic reaction sensitivity glutamate acid , polyethylene glycol , component test article product Subjects consume &gt; five alcoholic beverage per week Subjects pregnant lactating Subjects blood ( urine ) level outside normal range hepatic , renal , hematologic , lipid coagulation parameter measure . Subjects Hormone Replacement Therapy within past three month Subjects clinical trial experimental treatment past three month Subjects history diabetes ( Type 1 Type 2 diabetes mellitus ) endocrine disorder , hypertension , hypotension systolic blood pressure 80 mmHg , prior cerebrovascular accident seizure disorder , cardiovascular , hepatic renal disease , active cancer , hematologic disorder , thromboembolic disease , HIV infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Acute Radiation Syndrome</keyword>
	<keyword>ARS</keyword>
	<keyword>Amifostine</keyword>
	<keyword>Radio-protectants</keyword>
</DOC>